Sakar Healthcare Limited
NSE:SAKAR.NS
328.45 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Sakar Healthcare Limited |
Symbool | SAKAR.NS |
Munteenheid | INR |
Prijs | 328.45 |
Beurswaarde | 6,890,993,330 |
Dividendpercentage | 0% |
52-weken bereik | 295.15 - 479 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Sanjay Surendra Shah |
Website | https://www.sakarhealthcare.com |
An error occurred while fetching data.
Over Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)